• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral mycosis fungoides with CD30 large cell transformation successfully treated with brentuximab vedotin.

作者信息

Goggins Clare A, Gocke M Timothy, Jang Sekwon, DeSimone Jennifer A

机构信息

Georgetown University School of Medicine, Department of Dermatology, Washington, DC.

Virginia Oral Facial and Implant Surgery, McLean, Virginia.

出版信息

JAAD Case Rep. 2019 Jan 30;5(2):180-183. doi: 10.1016/j.jdcr.2018.11.013. eCollection 2019 Feb.

DOI:10.1016/j.jdcr.2018.11.013
PMID:30733988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6357896/
Abstract
摘要

相似文献

1
Oral mycosis fungoides with CD30 large cell transformation successfully treated with brentuximab vedotin.口服蕈样肉芽肿伴CD30大细胞转化经维布妥昔单抗治疗成功
JAAD Case Rep. 2019 Jan 30;5(2):180-183. doi: 10.1016/j.jdcr.2018.11.013. eCollection 2019 Feb.
2
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.对 Brentuximab vedotin 与医师选择的回应：根据 CD30 表达和大细胞转化状态在蕈样肉芽肿患者中的比较：ALCANZA 子分析。
Eur J Cancer. 2021 May;148:411-421. doi: 10.1016/j.ejca.2021.01.054. Epub 2021 Mar 29.
3
Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.大细胞转化蕈样肉芽肿患者的疾病特征、预后和对治疗的反应：一项单中心回顾性研究。
J Am Acad Dermatol. 2022 Jun;86(6):1285-1292. doi: 10.1016/j.jaad.2021.07.013. Epub 2021 Jul 14.
4
Dermal xanthomatous infiltrates after brentuximab vedotin therapy in mycosis fungoides with large-cell transformation: A novel histologic finding.在蕈样肉芽肿伴大细胞转化患者接受本妥昔单抗治疗后出现的皮肤黄色瘤样浸润：一种新的组织学发现。
J Cutan Pathol. 2018 May 27. doi: 10.1111/cup.13288.
5
Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.一名局限性蕈样霉菌病-大细胞转化患者对本妥昔单抗的即时反应
Case Rep Dermatol. 2023 Jul 14;15(1):110-116. doi: 10.1159/000529576. eCollection 2023 Jan-Dec.
6
Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin.蕈样肉芽肿病伴 CD30 阳性大细胞转化经 Brentuximab vedotin 治疗后成功缓解。
Dermatol Ther. 2020 Jan;33(1):e13152. doi: 10.1111/dth.13152. Epub 2019 Nov 19.
7
[Management of mycosis fungoide : focus on brentuximab vedotin].蕈样肉芽肿的管理：聚焦于维布妥昔单抗
Rev Med Liege. 2021 Apr;76(4):224-231.
8
Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.CD30 阴性、治疗抵抗的蕈样肉芽肿对 Brentuximab vedotin 治疗的显著反应。
Dermatol Ther. 2019 Mar;32(2):e12835. doi: 10.1111/dth.12835. Epub 2019 Feb 17.
9
Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.CD30、Ki-67和p53在辅助诊断蕈样肉芽肿伴大细胞转化中的应用。
J Cutan Pathol. 2019 Jan;46(1):33-43. doi: 10.1111/cup.13375. Epub 2018 Nov 14.
10
Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.在用维布妥昔单抗治疗的复发性皮肤CD30+淋巴样肿瘤中，通过免疫组织化学检测发现CD30表达存在可变缺失。
J Cutan Pathol. 2019 Nov;46(11):823-829. doi: 10.1111/cup.13545. Epub 2019 Aug 2.

引用本文的文献

1
Epiglottal involvement of mycosis fungoides.蕈样肉芽肿的会厌受累
JAAD Case Rep. 2025 Feb 21;59:6-8. doi: 10.1016/j.jdcr.2025.01.025. eCollection 2025 May.
2
Advances in classification and treatment of primary cutaneous lymphomas.原发性皮肤淋巴瘤的分类与治疗进展
Ann Hematol. 2025 Apr;104(4):2143-2157. doi: 10.1007/s00277-025-06311-3. Epub 2025 Mar 25.
3
Oral Mycosis Fungoides: Report of 2 Cases and Review of the Literature.口腔蕈样肉芽肿：2例报告及文献复习

本文引用的文献

1
Large Cell Transformation of Oral Mycosis Fungoides.口腔蕈样霉菌病的大细胞转化
Head Neck Pathol. 2018 Jun;12(2):247-251. doi: 10.1007/s12105-017-0840-z. Epub 2017 Jul 24.
2
Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome.与本妥昔单抗治疗蕈样肉芽肿和塞扎里综合征相关的周围神经病变的特征
J Neurooncol. 2017 May;132(3):439-446. doi: 10.1007/s11060-017-2389-9. Epub 2017 Mar 7.
3
Mycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene.
Case Rep Dermatol. 2023 Jul 12;15(1):1. doi: 10.1159/000530935. eCollection 2023 Jan-Dec.
4
Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.一名局限性蕈样霉菌病-大细胞转化患者对本妥昔单抗的即时反应
Case Rep Dermatol. 2023 Jul 14;15(1):110-116. doi: 10.1159/000529576. eCollection 2023 Jan-Dec.
5
A mutilating, persistent lip ulcer as a presenting sign of oral mycosis fungoides with large cell transformation.一种致残性、持续性唇部溃疡作为伴大细胞转化的口腔蕈样霉菌病的首发体征。
JAAD Case Rep. 2021 Feb 3;10:14-17. doi: 10.1016/j.jdcr.2021.01.023. eCollection 2021 Apr.
口腔蕈样霉菌病：用电子束放射治疗和维持使用贝沙罗汀成功治疗的溃疡性肿瘤
Case Rep Dermatol Med. 2016;2016:5857935. doi: 10.1155/2016/5857935. Epub 2016 Dec 15.
4
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.一项关于苯达莫司汀在不同CD30表达水平的蕈样肉芽肿和塞扎里综合征中应用的II期研究者发起研究：一项多机构合作项目。
J Clin Oncol. 2015 Nov 10;33(32):3750-8. doi: 10.1200/JCO.2014.60.3969. Epub 2015 Jul 20.
5
Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.17例蕈样肉芽肿转化前后临床与病理特征的相关性
Int J Dermatol. 2015 Sep;54(9):e327-31. doi: 10.1111/ijd.12875. Epub 2015 Jul 3.
6
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.蕈样肉芽肿伴大细胞转化：临床病理特征及预后因素
Pathology. 2014 Dec;46(7):610-6. doi: 10.1097/PAT.0000000000000166.
7
Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients.头颈部放疗的口腔不良反应：文献回顾及对放疗患者临床口腔护理指南的建议。
J Appl Oral Sci. 2011 Oct;19(5):448-54. doi: 10.1590/s1678-77572011000500003.
8
WHO-EORTC classification for cutaneous lymphomas.世界卫生组织-欧洲癌症研究与治疗组织皮肤淋巴瘤分类
Blood. 2005 May 15;105(10):3768-85. doi: 10.1182/blood-2004-09-3502. Epub 2005 Feb 3.